{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:29:21Z","timestamp":1794022161168,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016834","name":"Chongqing Municipal Health Commission","doi-asserted-by":"publisher","award":["2025WSJK123"],"award-info":[{"award-number":["2025WSJK123"]}],"id":[{"id":"10.13039\/100016834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108453","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:20:15Z","timestamp":1761146415000},"page":"108453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The immunoregulatory function and therapeutic potential of tetrandrine in connective tissue disease-associated interstitial lung disease"],"prefix":"10.1016","volume":"249","author":[{"given":"Qiuping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pulmoe.2023.11.007","article-title":"Early detection of interstitial lung disease in rheumatic diseases: a joint statement from the Portuguese pulmonology society, the Portuguese rheumatology society, and the Portuguese radiology and nuclear medicine society","volume":"31","author":"Morais","year":"2025","journal-title":"PULMONOLOGY"},{"key":"10.1016\/j.rmed.2025.108453_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684699","article-title":"Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations","volume":"12","author":"Shao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2025.108453_bib3","article-title":"Proteomics: potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.rmed.2025.108453_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103614","article-title":"Cardiovascular disease in connective tissue disease-associated interstitial lung disease: a systematic review and meta-analysis of observational studies","volume":"23","author":"Hu","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"167","key":"10.1016\/j.rmed.2025.108453_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0210-2022","article-title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","volume":"32","author":"Joy","year":"2023","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"LANCET RESP MED"},{"key":"10.1016\/j.rmed.2025.108453_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103900","article-title":"Unmet needs and emerging pharmacotherapies for autoimmune connective tissue disease-associated interstitial lung diseases","author":"Kondoh","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002850","article-title":"Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study","volume":"9","author":"Campochiaro","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib9","article-title":"Perception of the role of Telemedicine in Interstitial Lung Diseases: -findings from Societa Italiana di Pneumologia\/Italian Respiratory -Society (SIP-IRS) survey","volume":"20","author":"Monteleone","year":"2025","journal-title":"MULTIDISCIP RESP MED"},{"key":"10.1016\/j.rmed.2025.108453_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112727","article-title":"Autophagy and cancer: can tetrandrine be a potent anticancer drug in the near future?","volume":"148","author":"Bhagya","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.rmed.2025.108453_bib11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41401-021-00693-6","article-title":"Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages","volume":"43","author":"Song","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rmed.2025.108453_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156483","article-title":"Tetrandrine alleviates macrophage activation syndrome after CAR-T cell therapy","volume":"139","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.rmed.2025.108453_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123625","article-title":"Pulmonary administration of tetrandrine loaded zinc-alginate nanogels attenuates pulmonary fibrosis in rats","volume":"649","author":"Kou","year":"2024","journal-title":"INT J PHARMACEUT"},{"issue":"9842","key":"10.1016\/j.rmed.2025.108453_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2025.108453_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2020.100311","article-title":"Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management","volume":"8","author":"Yoo","year":"2021","journal-title":"EUR J RADIOL OPEN"},{"issue":"8","key":"10.1016\/j.rmed.2025.108453_bib16","first-page":"558","article-title":"[2018 chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases]","volume":"57","year":"2018","journal-title":"Zhonghua nei ke za zhi"},{"key":"10.1016\/j.rmed.2025.108453_bib17","article-title":"A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective","volume":"18","author":"Qin","year":"2023","journal-title":"CHIN MED-UK"},{"issue":"2","key":"10.1016\/j.rmed.2025.108453_bib18","article-title":"Differences in tolerability of antifibrotic agents between connective tissue disease-associated and non-connective tissue disease-associated interstitial lung disease","volume":"17","author":"Nakamura","year":"2025","journal-title":"CUREUS J MED SCIENCE"},{"issue":"04","key":"10.1016\/j.rmed.2025.108453_bib19","first-page":"543","article-title":"Study on interstitial lung disease associated with connective tissue disease in TCM","volume":"25","author":"Song-Wei","year":"2010","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib20","first-page":"20","article-title":"[research development on modern pharmacological effect of tetrandrine]","volume":"45","author":"Xi","year":"2020","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica"},{"key":"10.1016\/j.rmed.2025.108453_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117734","article-title":"Fangji huangqi decoction ameliorates membranous nephropathy through the upregulation of BNIP3-mediated mitophagy","volume":"324","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.rmed.2025.108453_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111700","article-title":"Tetrandrine inhibits the occurrence and development of frozen shoulder by inhibiting inflammation, angiogenesis, and fibrosis","volume":"140","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s10020-024-00981-x","article-title":"Tetrandrine induces muscle atrophy involving ROS-Mediated inhibition of akt and FoxO3","volume":"30","author":"Shan","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.rmed.2025.108453_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2017.01.014","article-title":"Inflammasomes in the lung","author":"Pinkerton","year":"2017","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108453_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58091194","article-title":"Tetrandrine treatment may improve clinical outcome in patients with COVID-19","volume":"58","author":"Chen","year":"2022","journal-title":"Medicina"},{"issue":"8","key":"10.1016\/j.rmed.2025.108453_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3899\/jrheum.220123","article-title":"Association of M2 macrophages, Th2, and B cells with pathomechanism in microscopic polyangiitis complicated by interstitial lung disease","volume":"49","author":"Matsuda","year":"2022","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.rmed.2025.108453_bib27","article-title":"Neutrophils modulate fibrogenesis in chronic pulmonary diseases","volume":"8","author":"Ding","year":"2021","journal-title":"FRONT MED-LAUSANNE"},{"issue":"7835","key":"10.1016\/j.rmed.2025.108453_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.rmed.2025.108453_bib29","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3892\/mmr.2016.5187","article-title":"Tetrandrine suppresses beta-glucan-induced macrophage activation via inhibiting NF-kappaB, ERK and STAT3 signaling pathways","volume":"13","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.rmed.2025.108453_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0026-895X(24)12518-7","article-title":"Anti-inflammatory effects of the partially purified extract of Radix stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions","volume":"60","author":"Shen","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11596-023-2725-6","article-title":"Tetrandrine represses inflammation and attenuates osteoarthritis by selective inhibition of COX-2","volume":"43","author":"Gao","year":"2023","journal-title":"CURR MED SCI"},{"key":"10.1016\/j.rmed.2025.108453_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8589121","article-title":"Tetrandrine ameliorates rheumatoid arthritis in mice by alleviating neutrophil activities","volume":"2022","author":"Lu","year":"2022","journal-title":"EVID-BASED COMPL ALT"},{"issue":"16","key":"10.1016\/j.rmed.2025.108453_bib33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.21037\/atm-20-5573","article-title":"Tetrandrine attenuates hyperoxia-induced lung injury in newborn rats via NF-kappaB p65 and ERK1\/2 pathway inhibition","volume":"8","author":"Jiao","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib34","first-page":"249","article-title":"Effects of tetrandrine on vascular permeability and neutrophil function in acute inflammation","volume":"10","author":"He","year":"1989","journal-title":"Zhongguo yao li xue bao = Acta pharmacologica Sinica"},{"issue":"2","key":"10.1016\/j.rmed.2025.108453_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2017.1389823","article-title":"Autophagy and inflammation in chronic respiratory disease","volume":"14","author":"Racanelli","year":"2018","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.rmed.2025.108453_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/toxics11090765","article-title":"Preliminary study on the effect and molecular mechanism of tetrandrine in alleviating pulmonary inflammation and fibrosis induced by silicon dioxide","volume":"11","author":"Wang","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.rmed.2025.108453_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176459","article-title":"Tetrandrine alleviates pulmonary fibrosis by inhibiting alveolar epithelial cell senescence through PINK1\/Parkin-mediated mitophagy","volume":"969","author":"Chu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108453_bib38","article-title":"Tetrandrine modulates Rheb-mTOR signaling-mediated selective autophagy and protects pulmonary fibrosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108453_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1145814","article-title":"Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases","volume":"14","author":"Hata","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","article-title":"Immune mechanisms in pulmonary fibrosis","volume":"55","author":"Kolahian","year":"2016","journal-title":"AM J RESP CELL MOL"},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib41","article-title":"Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): Genetics, cellular pathophysiology, and biologic drivers","volume":"24","author":"Cerro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000234542","article-title":"Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine","volume":"85","author":"Seow","year":"1988","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib43","first-page":"436","article-title":"The effects of traditional antirheumatic herbal medicines on immune response cells","volume":"24","author":"Chang","year":"1997","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108453_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00007890-199911150-00027","article-title":"Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology","volume":"68","author":"Lai","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.rmed.2025.108453_bib45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/imm.13500","article-title":"Tetrandrine, an immunosuppressive alkaloid isolated from steohania tetrandra S. Moore, induces the generation of treg cells through enhancing fatty acid oxidation","volume":"166","author":"Fang","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.rmed.2025.108453_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","article-title":"Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and treg cells via the aryl hydrocarbon receptor","volume":"101","author":"Yuan","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108453_bib48","first-page":"199","article-title":"The effects of tetrandrine (TT) and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and type III collagens during experimental silicosis","volume":"7","author":"Liu","year":"1994","journal-title":"Biomed. Environ. Sci."},{"issue":"5","key":"10.1016\/j.rmed.2025.108453_bib49","first-page":"412","article-title":"Effects of tetrandrine and chlorpromazine on synthesis of collagen and hyaluronic acid in cultured human lung fibroblasts","volume":"16","author":"Liu","year":"1995","journal-title":"Zhongguo Yaoli Xuebao"},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10753-023-01964-6","article-title":"Tetrandrine alleviates silica-induced pulmonary fibrosis through PI3K\/AKT pathway: network pharmacology investigation and experimental validation","volume":"47","author":"Ma","year":"2024","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.rmed.2025.108453_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16849","article-title":"Benzylisoquinoline alkaloids inhibit lung fibroblast activation mainly via inhibiting TGF-beta1\/Smads and ERK1\/2 pathway proteins","volume":"9","author":"Ren","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1378\/chest.11-1962","article-title":"Angiogenesis in pulmonary fibrosis: too much or not enough?","volume":"142","author":"Hanumegowda","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1248\/bpb.21.346","article-title":"Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells","volume":"21","author":"Kobayashi","year":"1998","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3892\/ijo.2014.2735","article-title":"Tetrandrine induces G1\/S cell cycle arrest through the ROS\/akt pathway in EOMA cells and inhibits angiogenesis in vivo","volume":"46","author":"Xiao","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.rmed.2025.108453_bib55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2017.10.116","article-title":"Tetrandrine and cancer - an overview on the molecular approach","volume":"97","author":"N","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib56","first-page":"388","article-title":"[effect of tetrandrine on pulmonary vascular morphology in rats with hypoxia pulmonary hypertension]","volume":"28","author":"Li","year":"1997","journal-title":"Journal of West China University of Medicalences"},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib57","first-page":"59","article-title":"[effect of tetrandrine on intraacinar pulmonary arterial structural remodelling and pulmonary hypertension]","volume":"27","author":"Zhang","year":"1996","journal-title":"Hua Xi Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"10.1016\/j.rmed.2025.108453_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ptr.8058","article-title":"Tetrandrine promotes the survival of the random skin flap via the PI3K\/AKT signaling pathway","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res."},{"issue":"12","key":"10.1016\/j.rmed.2025.108453_bib59","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nmat5024","article-title":"Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis","volume":"16","author":"Liu","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.rmed.2025.108453_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199258","article-title":"Tetrandrine (TET) inhibits African swine fever virus entry into cells by blocking the PI3K\/Akt pathway","volume":"339","author":"Qian","year":"2024","journal-title":"Virus Res."},{"issue":"6","key":"10.1016\/j.rmed.2025.108453_bib61","first-page":"473","article-title":"Research advances on the pharmacological effects of tetrandrine","volume":"9","author":"Cai","year":"2011","journal-title":"CHIN J NAT MEDICINES"},{"key":"10.1016\/j.rmed.2025.108453_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109673","article-title":"Tetrandrine attenuates SNI-Induced mechanical allodynia by inhibiting spinal CKLF1","volume":"238","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.rmed.2025.108453_bib63","series-title":"Primary Clinical Observation on Prevention and Treatment of radiation-induced Lung Injury by Tetrandrine","author":"Wang","year":"2010"},{"issue":"4","key":"10.1016\/j.rmed.2025.108453_bib64","first-page":"519","article-title":"Efficacy and safety of tetrandrine in treatment of rheumatoid arthritis: a meta-analysis","volume":"53","author":"Xu","year":"2024","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.rmed.2025.108453_bib65","article-title":"Research progress on anti-inflammatory effects and mechanisms of alkaloids from Chinese medical herbs","volume":"2020","author":"Li","year":"2020","journal-title":"EVID-BASED COMPL ALT"},{"issue":"2","key":"10.1016\/j.rmed.2025.108453_bib66","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3892\/etm.2020.8858","article-title":"Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function","volume":"20","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.rmed.2025.108453_bib67","article-title":"Clinical efficacy of tetrandrine in artificial stone-associated silicosis: a retrospective cohort study","volume":"10","author":"Wu","year":"2023","journal-title":"FRONT MED-LAUSANNE"},{"issue":"1","key":"10.1016\/j.rmed.2025.108453_bib68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12890-023-02577-3","article-title":"Tetrandrine slows the radiographic progression of progressive massive fibrosis in pneumoconiosis: a retrospective cohort study","volume":"23","author":"Tang","year":"2023","journal-title":"BMC Pulm. Med."},{"issue":"08","key":"10.1016\/j.rmed.2025.108453_bib69","first-page":"1447","article-title":"Clinical efficacy of tetrandrine in the adjunctive treatment of interstitial lung disease associated with connective tissue","volume":"23","author":"Yu","year":"2018","journal-title":"J. Clin. Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108453_bib70","series-title":"Clinical Observation of Tetrandrine in Treating Pulmonary Interstitial Fibrosis Caused by Connective Tissue Disease","author":"Yun-Jing","year":"2017"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:03:02Z","timestamp":1763690582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125005165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"alternative-id":["S0954611125005165"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108453","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunoregulatory function and therapeutic potential of tetrandrine in connective tissue disease-associated interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108453"}}